Mens Health | Womens Health News

Thursday, October 20, 2005

Smaller is better for thrombopoiesis-stimulating agents

The Business Intelligence firm La Merie S.L. recently analyzed the pipeline of thrombopoietin-stimulating agents. Main outcome of the search was that only two recombinant macromolecular proteins of the many projects initiated in the last decade are left. These protein projects are closely followed by oral small molecule and recombinant small protein developments which offer more convenience in dosing and less risk for immunogenicity... click link for more info.


Post a Comment

<< Home